- In April 2025, MED-EL Medical Electronics officially introduced its SONNET 3 Audio Processor, featuring integrated direct streaming capabilities. This allows users to stream audio directly from compatible Android and iPhone devices, smart TVs, and digital media players to their cochlear implants via Bluetooth Low Energy
- In May 2024, Cochlear Limited finalized its acquisition of Oticon Medical's cochlear implant business from Demant. This strategic move aims to strengthen Cochlear's market position and ensure continued support for existing Oticon Medical users
- In November 2023, GN Hearing, in collaboration with Soundly and artist Design Cells, launched a digital art campaign called "Inside the Ear." This initiative aims to increase awareness and education surrounding hearing health and demystify hearing loss through engaging animated videos
- In May 2023, Olympus announced FDA clearance for its new EVIS X1 endoscopy system. This system offers advanced imaging capabilities for gastrointestinal examinations, which directly benefits ENT diagnostics and minimally invasive surgical procedures by providing enhanced visualization
- In February 2023, KARL STORZ, a prominent medical technology company, acquired AventaMed DAC, an Irish medical technologies firm. This acquisition aimed to bolster KARL STORZ's ENT product portfolio by incorporating AventaMed's innovative Solo+ TTD device, which enhances tympanostomy procedures
- In November 2022, Cochlear Limited received U.S. FDA approval for its Nucleus 8 Sound Processor. This device is touted as the smallest and lightest behind-the-ear cochlear implant sound processor and the first ready to provide direct audio connectivity using the next-generation Bluetooth LE Audio technology
